Biotechnology Companies' Annual Reports & Investor Relations Material

582 Companies

BHVN

Biohaven Pharmaceutical Company

New Haven, Connecticut-based clinical-stage biopharmaceutical company Biohaven Ltd. is devoted to identifying, developing, and bringing to market therapies that treat debilitating neurological and ...

Biohaven Pharmaceutical Company Annual Report 2023

Healthcare Biotechnology NYSE 501-1000

EVG

Evgen Pharma plc

Eaton Vance Management has launched and managed a closed-ended fixed income mutual fund known as the Eaton Vance Short Duration Diversified Income Fund. Focusing on fixed income markets in the Unit...

Evgen Pharma plc Annual Report 2023

Healthcare Biotechnology LSE 1-10

IMM

ImmuPharma- Plc

ImmuPharma is a London-based biopharmaceutical company that specializes in peptide-based therapeutics for a range of therapy areas, including autoimmunity, metabolism, anti-infectives, and cancer. ...

ImmuPharma- Plc Annual Report 2023

Healthcare Biotechnology LSE 11-50

ALKS

Alkermes

Dublin-based biopharmaceutical company Alkermes plc is making waves in the industry thanks to its groundbreaking pharmaceutical products catered towards unmet medical needs in various therapeutic a...

Alkermes Annual Report 2023

Healthcare Biotechnology NASDAQ 1001-5000

NAVB

Navidea Biopharmaceuticals

Biopharmaceutical company Navidea Biopharmaceuticals, Inc. is focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics, operating in two segments...

Navidea Biopharmaceuticals Annual Report 2021

Healthcare Biotechnology NYSE 51-200

QGEN

Qiagen

Dutch-based biotech company QIAGEN N.V. is revolutionizing the field of molecular biology on a global scale with its "sample to insight" solutions. Boasting a wide range of products and services, Q...

Qiagen Annual Report 2023

Healthcare Biotechnology NASDAQ 1001-5000

HEPA

Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc., a biopharmaceutical firm, is making significant strides towards developing drug therapy for chronic liver ailments in the United States. Its focus is centered on bring...

Hepion Pharmaceuticals, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

CFRX

Contrafect Corp

ContraFect Corporation, a clinical-stage biotech firm, has made breakthroughs in developing protein and antibody treatments for life-threatening and drug-resistant infectious diseases. The company'...

Contrafect Corp Annual Report 2021

Healthcare Biotechnology NASDAQ 11-50

PAA

Plains All American Pipeline

Houston-based Plains All American Pipeline, L.P. and its subsidiaries are involved in the pipeline transportation, terminalling, storage, and gathering of crude oil and natural gas liquids (NGL) in...

Plains All American Pipeline Annual Report 2020

Healthcare Biotechnology ASX 51-200

ATHE

Alterity Therapeutics Limited

Australian biotech company, Alterity Therapeutics Limited, is aiming to combat several neurological disorders - including Alzheimer's, Huntington's, and Parkinson's diseases - by developing therape...

Alterity Therapeutics Limited Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

ADMA

ADMA Biologics

ADMA Biologics, Inc., a biopharmaceutical firm, has taken on the task of developing, producing, and marketing specialty plasma-derived biologics. The firm, which operates both in the United States ...

ADMA Biologics Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

PRTK

Paratek Pharmaceuticals

Paratek Pharmaceuticals, Inc. is making significant strides in the commercial-stage biopharmaceutical industry with its focus on developing and bringing to market life-saving therapies for life-thr...

Paratek Pharmaceuticals Annual Report 2021

Healthcare Biotechnology NASDAQ 11-50

PHAT

Phathom Pharmaceuticals

Florham Park, New Jersey-based biopharmaceutical firm, Phathom Pharmaceuticals, Inc., is dedicated to the development and commercialization of innovative treatments for gastrointestinal diseases. T...

Phathom Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

PDSB

PDS Biotechnology

PDS Biotechnology Corporation, based in Florham Park, New Jersey, is making headlines for spearheading the development of multifunctional cancer immunotherapies. Founded in 2005, the clinical-stage...

PDS Biotechnology Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

PFNX

Pfenex Inc

San Diego-based biotechnology company Pfenex Inc. has made significant strides in the development of biosimilar therapeutics. With a focus on ophthalmology, the firm's lead product candidate PF582 ...

Pfenex Inc Annual Report 2018

Healthcare Biotechnology NYSE 51-200